PAGLIARO, MARTINA
PAGLIARO, MARTINA
Clinical and Market Analysis of NanoBEO: A Public-Worth, Innovative Therapy for Behavioral and Psychological Symptoms of Dementia (BPSD)—Emerging Evidence and Its Implications for a Health Technology Assessment (HTA) and Decision-Making in National Health Systems
2024-01-01 Scuteri, D.; Pierobon, D.; Pagliaro, M.; Hamamura, K.; Hayashi, T.; Pignolo, L.; Nicotera, P.; Bagetta, G.; Corasaniti, M. T.
Combination of anti-CGRP/CGRP-R mAbs with onabotulinumtoxin A as a novel therapeutic approach for refractory chronic migraine: a retrospective study of real-world clinical evidence and a protocol for a double-blind, randomized clinical trial to establish the efficacy and safety
2023-01-01 Corasaniti, M. T.; Lawrence, G. W.; Bagetta, G.; Iannacchero, R.; Tarsitano, A.; Monteleone, A.; Pagliaro, M.; Tonin, P.; Sandrini, G.; Nicotera, P.; Scuteri, D.
Efficacy of therapeutic intervention with NanoBEO to manage agitation and pain in patients suffering from severe dementia: a pilot clinical trial
2024-01-01 Scuteri, Damiana; Pagliaro, Martina; Mantia, Isabel; Contrada, Marianna; Pignolo, Loris; Tonin, Paolo; Nicotera, Pierluigi; Bagetta, Giacinto; Corasaniti, Maria Tiziana; Null, Null
Proposal of combination therapies to treat refractory chronic migraine
2023-01-01 Scuteri, D.; Pagliaro, M.; Monteleone, A.; Tarsitano, A.; Iannacchero, R.; Vulnera, M.; Sandrini, G.; Tonin, P.; Bagetta, G.; Corasaniti, M. T.